Cipla House
Peninsula Business Park Ganpatrao Kadam Marg Lower Parel
Mumbai 400013
India
91 22 2482 6000
https://www.cipla.com
Sector(es): Healthcare
Industria: Drug Manufacturers - General
Empleados a tiempo completo:
Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
---|---|---|---|---|
Mr. Umang Vohra B.E., M.B.A. | MD, Global CEO & Executive Director | 174.9M | N/D | 1971 |
Dr. Raju Sunil Mistry M.A., Ph.D. | President & Global Chief People Officer | N/D | N/D | 1965 |
Mr. Pradeep Bhadauria | President & Chief Scientific Officer | N/D | N/D | N/D |
Mr. Ashish Adukia | Global Chief Financial Officer | N/D | N/D | N/D |
Mr. Dinesh Ramniranjan Jain | Senior VP & Head of Corporate Finance | N/D | N/D | N/D |
Cipla Limited, together with its subsidiaries, manufactures, develops, and sells pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New ventures segments. It also offers active pharmaceutical ingredients; and formulations in various therapeutic areas, such as MI, angina, heart failure, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, HIV, respiratory, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women's health, ophthalmology, and neuro psychiatry. In addition, the company provides respiratory products, including inhalers and nasal sprays, as well as other respiratory products consists of injectables and biosimilars. Further, it offers Easylax and Easylax L, a liquid paraffin for constipation. Cipla Limited was incorporated in 1935 and is based in Mumbai, India.
La calificación ISS Governance QuickScore de Cipla Limited a partir del 1 de junio de 2024 es 3. Las puntuaciones principales son Auditoría: 4; Junta: 2; Derechos del accionista: 1; Compensación: 8.